Aller au contenu principal

Psychiatrie-Comorbidités-Addictions (PSYCOMadd)

Les 20 dernières publications

Titre Auteurs Date de publication Source
Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Bruno Roméo, Amine Benyamina 01/03/2024 Alcohol and Alcoholism
Opinions of French psychiatrists on the regulatory status of cannabis: Results from the “PsyCan – Encéphale” national online survey Amine Benyamina 01/01/2024 L'Encephale
Women and alcohol: From risky use to addiction, the issues at stake L. Karila 01/12/2023 Revue de l'Infirmiere
Women and alcohol, the addictologist's point of view and treatment Amine Benyamina 01/12/2023 Revue de l'Infirmiere
Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey Vincent Verroust 01/12/2023 Scientific Reports
Antioxidant Effects of Catechins (EGCG), Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update Raphaël Serreau 01/07/2023 Antioxidants
Articulating acceptance and commitment therapy to psychedelic-assisted psychotherapy in addictology Lana Strika-Bruneau, Amine Benyamina 01/06/2023 Evolution Psychiatrique
Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort Amine Benyamina 01/04/2023 L'Encephale
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey Bruno Roméo, L. Strika, Ammar Amirouche, Vincent Verroust, Amine Benyamina 01/01/2023 Journal of Psychoactive Drugs
Development, psychometric validation, and cross-cultural comparison of the "Instagram Motives Questionnaire" (IMQ) and the "Instagram Uses and Patterns Questionnaire" (IUPQ) L. Karila 01/01/2023 Journal of Behavioral Addictions
A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe Raphaël Serreau, Ammar Amirouche, Amine Benyamina 01/01/2023 Pharmaceuticals
Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis Ophélie Rault, Bruno Roméo, Eirini Rari, Amine Benyamina, Catherine Martelli 01/12/2022 Journal of Psychiatric Research
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs Vincent Verroust 01/11/2022 European Neuropsychopharmacology
Changes in Alcohol Consumption among Users of an Internet Drug Forum during a COVID-19 Lockdown Alain Dervaux 01/11/2022 International Journal of Environmental Research and Public Health
Cannabidiol in the context of substance use disorder treatment: A systematic review Victoria Paulus, Amine Benyamina, L. Karila 01/09/2022 Addictive Behaviors
Women who use illicit substances Sarah Coscas, L. Karila, Amine Benyamina 01/01/2022 Revue Sage - Femme
Cannabis Cessation, Inflammatory Markers and Schizophrenia Bruno Roméo, Catherine Martelli, Amine Benyamina, Nora Hamdani 01/01/2022 Journal of Dual Diagnosis
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment during Clozapine Treatment: A Case Report Bruno Roméo, Eirini Rari 01/01/2022 Journal of Clinical Psychopharmacology
First-episode psychosis following vaccination against yellow fever: A case report Bruno Roméo, Eirini Rari, A. Mazari, A. Toullec, Catherine Martelli, Amine Benyamina 01/12/2021 L'Encephale
Editorial: Purple Haze: Issues on Cannabis Legalization Amine Benyamina 10/11/2021 Frontiers in Psychiatry

Nombre de publications du laboratoire par domaine scientifique (2016-2021)

Chaque publication du laboratoire peut être rangée dans une ou plusieurs disciplines scientifiques : la figure ci-dessus présente le nombre de publications du laboratoire pour chaque discipline de la classification ASJC (Elsevier)